Children's Hospital Boston launches science and clinical innovation blog

Children's Hospital Boston launches science and clinical innovation blog  

Bess Andrews, Public Affairs
Children's Hospital Boston
[email protected]

Vector, Children's Hospital Boston's new blog, goes public today, covering hot and timely topics in biomedicine with a special interest in the scientific, business and policy issues affecting the translation of discovery to patient care. The blog is written by and for scientists, clinicians, inventors, innovators and followers of the latest discoveries, topics and trends in science and medicine.  Contributors are from within Children's and from outside stakeholders.
Replacing Children's print magazine of the same name that covered similar topics in greater depth, Vector blog is a timely, quick read designed to bring readers up to date on the latest news from Children's and beyond. It will also cover issues related to biomedical ethics, research funding and other topics critical to the success of research advances.
Check out embryonic stem cell researcher Dr. George Daley's post on pluripotent stem cells as a platform for drug discovery, neurosurgeon Dr. Joseph Madsen's post on "bridge building" as a means to advance  translation in medicine, patent attorney David Resnick's controversial post on patenting genes, and psychologist-inventor Dr. Eugene Goldfield on how he developed the idea for "smart clothing" to help babies with cerebral palsy.  Also find a link to a roundtable dicussion in Nature with Children's attorney and ethicist Patrick Taylor on the recent flip- flop on the use of NIH funds for stem cell research and more.
 Read Vector blog (, join the Vector Facebook page ( and sign up for the Vector Twitter feed
Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 12 members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 396-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit:

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.